CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, CHIEF MEDICAL OFFICER sold 4,317 shares at $8.80 ($37,990)
- 4 Planned sale CEO sold 6,486 shares at $9.50 ($61,638)
- 4 Planned sale EVP, CBO AND CTO sold 105 shares at $9.50 ($998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP, CHIEF FINANCIAL OFFICER acquired 77,900 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 949 shares at $9.87 ($9,369)
- 4 Planned sale EVP, CBO AND CTO sold 668 shares at $9.87 ($6,594)
- 4 Planned sale EVP, CBO AND CTO sold 135 shares at $9.51 ($1,284)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 184 shares at $8.89 ($1,636)
- 4 Grant or award SVP, CHIEF MEDICAL OFFICER acquired 18,000 shares (grant or award)
Page 5 of 18 · 351 filings